NLRP3 and cardiac hypertrophy: The findings of the present study indicate that chronic Ang II stimulation could activate cardiac oxidative damage and NLRP3 inflammasome-mediated inflammation, leading to cardiac hypertrophy and dysfunction, accompanied by MHRT inhibition.